PubMed · 2014 · 28 citations · 15 references
MedicineClinical SciencesSurgeryGastroenterologyGastrointestinal PharmacotherapyGeneral SurgeryEsophageal DiseasesEsophageal SurgeryGastroesophageal Reflux DiseaseGastrointestinal SurgeryLaparoscopic SurgeryMinimally Invasive SurgeryAnti-reflux SurgeryManagement Of Barrett's EsophagusMinimally Invasive Esophageal SurgeryMinimally Invasive ImplantationOutcome MeasuresPrimary Outcome AnalysisSerious Adverse EventsSurgical Management Of Gerd
BACKGROUND: Gastroesophageal reflux disease (GERD) is a common chronic disease requiring adequate treatment since it represents one major cause of development of Barrett's esophagus and eventually carcinoma. Novel laparoscopic magnetic sphincter augmentation for GERD was evaluated prospectively. PATIENTS AND METHODS: A total of 23 patients with GERD underwent minimally invasive implantation of LINX™ Reflux Management System. Primary outcome measures were overall feasibility, short-term procedure safety and efficacy. Secondary GERD-related quality of life was assessed. RESULTS: All implantations were performed without serious adverse events. A significant decrease in all major GERD complaints were found: heartburn: 96%-22% (p<0.001); bloating: 70%-30% (p=0.006); respiratory complaints: 57%-17% (p=0.039); sleep disturbance: 65%-4% (p<0.001). A four-week follow-up reduction of ≥50% of proton pump inhibitor (PPI) dose was achieved in over 80% of patients. Self-limiting difficulty in swallowing was found in 70% within four weeks. One patient required for endoscopic dilation. GERD-related quality of life improved significantly. CONCLUSION: LINX™ implantation is a standardized, technically simple, safe and well-tolerated expeditious procedure.
15
Esophageal Sphincter Device for Gastroesophageal Reflux Disease
Robert A. Ganz, Jeffrey H. Peters, Santiago Horgan et al. · New England Journal of Medicine · 2013 · 321 citations · Full text
Medicine, Clinical Sciences, Surgery +16